Künzel Stephan R, Günther Claudia
Klinik und Poliklinik für Dermatologie, Medizinische Fakultät und Universitätsklinikum Carl Gustav Carus Dresden, Fetscherstr. 74, Dresden, Deutschland.
Institut für Transfusionsmedizin, Medizinische Fakultät Carl Gustav Carus, Blasewitzerstr. 68/70, 01307, Dresden, Deutschland.
Dermatologie (Heidelb). 2024 Mar;75(3):214-217. doi: 10.1007/s00105-023-05292-6. Epub 2024 Jan 19.
Radiation-induced morphea is a fibro-inflammatory remodelling process of the subcutaneous connective tissue caused by ionising radiation, most commonly in the context of breast cancer treatment. The underlying pathomechanisms and putative risk factors are unknown. Therefore, misdiagnosis and inappropriate treatment pose a significant problem in the care of those patients.
The aim of the study was to provide an overview as well as guidance for the diagnosis and treatment of radiation-induced morphea based on current case reports and review articles.
Radiation-induced morphea is a rare condition that represents an interdisciplinary challenge for (gynaecological) oncology, radiotherapy and dermatology. Frequent misdiagnoses include infection (erysipelas), cancer recurrence or radiation dermatitis. Early histological diagnosis and the initiation of anti-inflammatory therapy using topical glucocorticoids or calcineurin inhibitors in combination with phototherapy and/or methotrexate are the most relevant success factors for an adequate clinical response.
放射性硬斑病是一种由电离辐射引起的皮下结缔组织纤维炎性重塑过程,最常见于乳腺癌治疗背景下。其潜在的发病机制和假定的风险因素尚不清楚。因此,误诊和不恰当的治疗给这些患者的护理带来了重大问题。
本研究旨在基于当前的病例报告和综述文章,对放射性硬斑病的诊断和治疗提供概述及指导。
放射性硬斑病是一种罕见疾病,对(妇科)肿瘤学、放射治疗学和皮肤病学而言是一个跨学科挑战。常见的误诊包括感染(丹毒)、癌症复发或放射性皮炎。早期组织学诊断以及使用外用糖皮质激素或钙调神经磷酸酶抑制剂联合光疗和/或甲氨蝶呤启动抗炎治疗是获得充分临床反应的最关键成功因素。